On the other hand, elevated serum lactate dehydrogenase levels (LDH) and C-reactive protein (CRP) have been proposed as potential biomarkers to predict the outcome in some patients with PRES; however, the most findings were based on a small group of patients (16, 62, 66, 67). This evidence concerns the gene CRP and Posterior Leukoencephalopathy Syndrome.